首页> 外文期刊>Health economics >Health systems in East Asia: what can developing countries learn from Japan and the Asian Tigers?
【24h】

Health systems in East Asia: what can developing countries learn from Japan and the Asian Tigers?

机译:东亚的卫生系统:发展中国家可以从日本和亚洲四小龙中学到什么?

获取原文
获取原文并翻译 | 示例
       

摘要

The health systems of Japan and the Asian Tigers (Hong Kong, Korea, Singapore and Taiwan), and the recent reforms to them, provide many potentially valuable lessons to East Asia's developing countries. All five systems have managed to keep a check on health spending despite their different approaches to financing and delivery. These differences are reflected in the progressivity of health finance, but the precise degree of progressivity of individual sources and the extent to which households are vulnerable to catastrophic health payments depend on the design features of the system - the height of any ceilings on social insurance contributions, the fraction of health spending covered by the benefit package, the extent to which the poor face reduced copayments, whether there are caps on copayments, and so on. On the delivery side, too, Japan and the Tigers offer some interesting lessons. Singapore's experience with corporatizing public hospitals - rapid cost and price inflation, a race for the best technology, and so on - illustrates the difficulties of corporatization. Korea's experience with a narrow benefit package illustrates the danger of providers shifting demand from insured services with regulated prices to uninsured services with unregulated prices. Japan, in its approach to rate setting for insured services, has managed to combine careful cost control with fine-tuning of profit margins on different types of care. Experiences with DRGs in Korea and Taiwan point to cost-savings but also to possible knock-on effects on service volume and total health spending. Korea and Taiwan both offer important lessons for the separation of prescribing and dispensing, including the risks of compensation costs outweighing the cost savings caused by more 'rational' prescribing, and cost-savings never being realized because of other concessions to providers, such as allowing them to have onsite pharmacists.
机译:日本和亚洲四小龙(香港,韩国,新加坡和台湾)的卫生系统以及对它们的最新改革,为东亚发展中国家提供了许多潜在的宝贵经验。尽管这五个系统在筹资和交付方式上有所不同,但它们仍设法检查了卫生支出。这些差异反映在卫生资金的累进性上,但是单个来源的累进性确切程度以及家庭容易遭受灾难性健康支付的程度取决于系统的设计特征-社会保险缴费上限的高度,一揽子福利计划所覆盖的医疗支出的比例,穷人面临的共付额减少程度,共付额是否有上限等。在交付方面,日本和老虎也提供了一些有趣的课程。新加坡在公立医院公司化方面的经验-快速的成本和价格上涨,对最佳技术的争夺等等-说明了公司化的困难。韩国从一揽子福利计划中获得的经验表明,提供者有可能将需求从受管制价格的带保险服务转移到不受管制价格的无保险服务。日本在确定被保险服务费率的方法中,已经设法将谨慎的成本控制与微调不同类型护理的利润率结合起来。在韩国和台湾使用DRG的经验表明,可以节省成本,但也可能对服务量和医疗总支出产生连锁反应。韩国和台湾地区都为区分处方和配药提供了重要的经验教训,其中包括补偿成本的风险超过了更多“理性”处方所带来的成本节省,以及由于提供方的其他让步而导致成本节省从未实现,例如允许他们要有现场药剂师。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号